Inventor
BRIAN ALAN LANMAN
Inventor
US
Overview
Patents· 15 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes31%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07DHeterocyclic compounds29%
C07BGeneral methods of organic chemistry2%
C07KPeptides2%
G01CMeasuring distances, levels or bearings2%
G06QInformation and communication technology [ict] specially adapted for administrative, commercial, financial, managerial or supervisory purposes2%
Y02ATechnologies for adaptation to climate change2%
PatentTitleYear
12,583,854KRAS G12C inhibitors and methods of using the same202612,570,672Macrocyclic compounds and methods of use202612,440,491KRAS G12C inhibitors and methods of using the same202512,083,121Substituted piperazines as KRAS G12C inhibitors202411,993,597Inhibitors of KRAS G12C and methods of using the same202411,905,281KRAS G12C inhibitors and methods of using the same202411,845,760PRMT5 inhibitors202311,807,693Apelin polypeptides202311,766,436KRAS G12C inhibitors and methods of using the same202311,364,248Compounds that inhibit Mcl-1 protein202211,306,087Inhibitors of KRAS G12C and methods of using the same202211,285,135KRAS G12C inhibitors and methods of using the same202211,285,156Substituted piperazines as KRAS G12C inhibitors202211,279,712Macrocyclic compounds that inhibit MCL-1 protein202211,224,601Compounds that inhibits MCL-1 protein2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to AMGEN INC (15)· patent assignee history
2022–2026Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AMGEN INC | 15 | 2022–2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 15 | 2022–2026 |